198 related articles for article (PubMed ID: 1164059)
1. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
McBride CM; Sugarbaker EV; Hickey RC
Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
[TBL] [Abstract][Full Text] [Related]
2. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.
Sugarbaker EV; McBride CM
Cancer; 1976 Jan; 37(1):188-98. PubMed ID: 1247954
[TBL] [Abstract][Full Text] [Related]
3. Regional chemotherapy for melanoma. A 35-year experience.
Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
Kroon BB; Schraffordt Koops H
Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
[TBL] [Abstract][Full Text] [Related]
5. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
Alrich EM; Manwaring JL; Horsley JS
Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
[No Abstract] [Full Text] [Related]
6. Survival after regional perfusion for limb melanoma.
Cox KR
Aust N Z J Surg; 1975 Feb; 45(1):32-6. PubMed ID: 808204
[TBL] [Abstract][Full Text] [Related]
7. Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
Bulman AS; Jamieson CW
Br J Surg; 1980 Sep; 67(9):660-2. PubMed ID: 7427069
[TBL] [Abstract][Full Text] [Related]
8. [Regional chemotherapy--perfusion of the extremities].
Meyer T; Göhl J
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ
J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
[TBL] [Abstract][Full Text] [Related]
11. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
Binder J; Henneking K
Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
[TBL] [Abstract][Full Text] [Related]
12. Effective therapy: repeat limb perfusion for recurrent melanoma.
Krementz ET
J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
[No Abstract] [Full Text] [Related]
13. Effect of variation of drug dosage on disease control and regional toxicity in prophylactic perfusion for Stage I extremity melanoma.
Mikhail RA; Boddie AW; Ames FC; Zimmerman SO; McBride CM
J Surg Oncol; 1984 Dec; 27(4):215-8. PubMed ID: 6503295
[TBL] [Abstract][Full Text] [Related]
14. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
15. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
Ariyan S; Poo WJ; Bolognia J
Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898
[TBL] [Abstract][Full Text] [Related]
16. Surgical issues in the management of melanoma.
Fraker DL
Curr Opin Oncol; 1997 Mar; 9(2):183-8. PubMed ID: 9161799
[TBL] [Abstract][Full Text] [Related]
17. Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard.
Hartley JW; Fletcher WS
J Surg Oncol; 1987 Nov; 36(3):170-4. PubMed ID: 3682836
[TBL] [Abstract][Full Text] [Related]
18. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
Schraffordt Koops H; Oldhoff J
Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
[TBL] [Abstract][Full Text] [Related]
19. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
Huber R; Krüger I; Stützer H
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
Hafström L; Jönsson PE
Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
